Home » Topics » BioWorld Science

BioWorld Science
RSS

Overcoming aggravations in studying aggregation

Sep. 12, 2018

Probiotics: not all that

Sep. 12, 2018

AstraZeneca initiates first-in-human study of AZD-8233

Sep. 10, 2018

Sareum selects SDC-1801 from TYK2 inhibitor program for advancement in autoimmune diseases

Sep. 10, 2018

Roche opens enrollment in phase III study of RO-6867461 for DME

Sep. 10, 2018

Grifols signs agreement to support research in rare and chronic diseases

Sep. 10, 2018

FDA issues complete response letter for mepolizumab in COPD

Sep. 10, 2018

CureDuchenne invests in 4D Molecular Therapeutics

Sep. 10, 2018

ZNF281 inhibits neuronal differentiation and predicts the prognosis of neuroblastoma

Sep. 10, 2018

Oryzon receives approval to initiate phase IIa REIMAGINE study of vafidemstat in aggressiveness

Sep. 10, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...